Clinitech Laboratory IPO
GMP, Subscription, Price, Dates & Financial Details
Founded in 1990, Clinitech Laboratory Limited provides diagnostic and health testing and services.The company performs more than 150 tests in its centres, which are divided into different categories: Biochemical Tests, Immunology Tests, Hematology Tests, Molecular Biology Tests, Serology Tests,…
Open Date
Thu, 25 Jul 2024
Close Date
Mon, 29 Jul 2024
Issue Price
₹ 96
Lot Size
1200
Issue Size
₹ 5.78 Cr
Minimum Investment
₹ 230,400 (2400 Shares)
Grey Market Premium Analysis
Day Wise GMP→Unofficial premium quoted in the grey market, tracked daily against the price band cap.
Grey market trading is unregulated. GMP figures are indicative only and should not be the sole basis for investment decisions - treat as a sentiment indicator, not a guarantee.
IPO Details
Clinitech Laboratory IPO has successfully completed its IPO process and is now listed on BSE SME Platform. According to the Red Herring Prospectus (RHP), the IPO was a fixed price issue with a total issue size of ₹6 Crore, comprising a fresh issue of 6.02 Lakh equity shares aggregating to ₹5.78 Crore.
The Clinitech Laboratory IPO remained open for subscription from July 25, 2024, to July 29, 2024. The basis of allotment was finalized on July 30, 2024, and the company's shares were listed on BSE SME Platform on August 01, 2024.
The company had fixed the price at ₹96 per share, with a lot size of 1200 shares. Retail investors were required to make a minimum investment of ₹230,400 (based on the upper price band) to apply for one lot.
Bigshare Services Pvt Ltd served as the registrar to the issue. Inventure Merchant Banker Services Pvt Ltd acted as the Book Running Lead Managers (BRLMs) to the issue.
With the successful completion of the IPO process, Clinitech Laboratory Limited is now a publicly listed company on BSE SME Platform. Investors can track the company's share price, trading performance, financial results, and corporate announcements through the stock exchanges.
Clinitech Laboratory IPO Timeline (Tentative)
- IPO Open Date
- Thu, 25 Jul 24
- IPO Close Date
- Mon, 29 Jul 24
- Basis of Allotment
- Tue, 30 Jul 24
- Initiation of Refunds
- Wed, 31 Jul 24
- Credit of Shares to Demat
- Wed, 31 Jul 24
- Listing Date
- Thu, 01 Aug 24 — NSE & BSE
Open Date
25 July 2024
Close Date
29 July 2024
Basis Of Allotment
30 July 2024
Listing Date
01 August 2024
IPO Subscription
Check Live Subscription →The Clinitech Laboratory IPO has received bids for 2,22,55,200 shares against 5,71,200 shares offered, resulting in an overall subscription of 38.96x. Retail Investors 49.61x, and Others 23.28x.
Others
23.28x
RII
49.61x
Total
38.96x
IPO Reservations
The Retail Individual Investor (RII) category has the highest allocation with 2,85,600 shares, representing 47.41% of the total issue. Qualified Institutional Buyers (QIBs) are allocated 0 shares (%), while Non-Institutional Investors (NIIs) receive 0 shares (%).
| Category | Shares Offered | Shares Offered |
|---|---|---|
| Market Maker | 31,200 | 5.18% |
| Others | 285,600 | 47.41% |
| Retail Investors | 285,600 | 47.41% |
| Total | 602,400 | 100% |
Financials Details(₹ in Crores)
| Particular | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 | 31 Mar 2021 |
|---|---|---|---|---|
| Assets | 560.79 | 603.33 | 368.74 | 273.32 |
| Revenue | 643.92 | 636.34 | 645.7 | 459.63 |
| Profit After Tax | 37.12 | 61.31 | 51.26 | 40.24 |
| Net Worth | 354.8 | 238.08 | 184.81 | 139.03 |
| Reserve & Surplus | 186.8 | 88.08 | 34.81 | 72.37 |
| Total Borrowings | 86.31 | 102.91 | 88.61 | 53.67 |
Financials Performance
Performance Indicators
EPS Pre
Earnings per share before the IPO.
P/E Pre
IPO Offer Price ÷ EPS Pre.
EPS Post
Expected earnings per share after the IPO..
P/E (Post Issue)
IPO Offer Price ÷ EPS Post.
Clinitech Laboratory Limited KPI Information
| Particular | |
|---|---|
| Debt / Equity | 0.24 |
| RoNW % | 10.46 |
| PbW | 4.55 |
| Pat Margin % | 5.76 |
Peers Comparison
No Peer Comparision Available
About Clinitech Laboratory Limited
Founded in 1990, Clinitech Laboratory Limited provides diagnostic and health testing and services.
The company performs more than 150 tests in its centres, which are divided into different categories: Biochemical Tests, Immunology Tests, Hematology Tests, Molecular Biology Tests, Serology Tests, Microbiology Tests and Histopathology Tests.
Clinitech Laboratory has eight diagnostic centres around Thane and Navi Mumbai. The company conducts more than 3 lakh tests per year in its NABL (National Accreditation Board for Testing and Calibration Laboratories) accredited laboratories equipped with modern technology and high quality equipment.
The company's medical testing facilities at Airoli, Navi Mumbai, have been accredited by NABL (National Accreditation Board for Testing and Calibration Laboratories) as per ISO 15189:2012.
As of May 31, 2024, the company employed 85 people in various departments.
Clinitech Laboratory IPO Promoters
Jagdish Umakant Nayak, Jyoti Jagdish Nayak, and Ashutosh Jagdish Nayak
Promoters Holding
Holding Pre Issue
83.63%
Holding Post Issue
61.56%
Clinitech Laboratory IPO Objective
The Company proposes to utilize the Net Proceeds from the Fresh Issue towards funding the following objects:
Expansion of Diagnostic Centres.
General Corporate Purposes.
Clinitech Laboratory Limited Address / Contact Details
IPO Snapshot
Clinitech Laboratory IPO Lot Size
The Clinitech Laboratory IPO has a lot size of 1,200 shares. Retail investors require a minimum investment of ₹1,15,200 by applying for 1 lot (1,200 shares). The maximum application allowed for the retail category is 1 lots (1,200 shares), requiring an investment of ₹1,15,200.
| Application | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 1,200 | 115,200.00 |
| Retail (Max) | 1 | 1,200 | 115,200.00 |
| S-HNI (Min) | 2 | 2,400 | 230,400.00 |
Issue Reservation
- Market Maker — 5.18%
- Others — 47.41%
- RII — 47.41%
Book Running Lead Managers
- Inventure Merchant Banker Services Pvt Ltd
IPO Documents & Links
Explore More IPOs
Currently Open
Coming Up Next
Disclaimer: This data is for informational purposes only and does not constitute investment advice.
Frequently Asked Questions
Everything you need to know before applying to an IPO.
What is the Clinitech Laboratory IPO?
Clinitech Laboratory IPO is a with a total issue size of ₹5.78 crore. The Clinitech Laboratory IPO price band is ₹96 to 96 per share. The Clinitech Laboratory IPO subscription opens on Thu, Jul 25, 2024, and closes on Mon, Jul 29, 2024. The Clinitech Laboratory IPO will be listed on the BSE. Bigshare Services Pvt Ltd is the registrar for the Clinitech Laboratory IPO.
When will the Clinitech Laboratory IPO open for subscription?
The Clinitech Laboratory IPO opens on Thu, Jul 25, 2024 and closes on Mon, Jul 29, 2024
What is Clinitech Laboratory IPO Price Band?
Clinitech Laboratory IPO Price Band is ₹96 to 96 per share.
What is Clinitech Laboratory IPO Lot Size?
Clinitech Laboratory IPO lot size is 1200 shares, Retail investors need a minimum investment of ₹230400 based on the upper price band
What is the minimum investment for Clinitech Laboratory IPO?
The minimum investment for Clinitech Laboratory IPO is ₹230400, based on one lot of 1200 shares at the upper price band of ₹96 per share.
How to apply for Clinitech Laboratory IPO?
Investors can apply for the Clinitech Laboratory IPO through the ASBA (Application Supported by Blocked Amount) facility offered by their bank or through UPI using a SEBI-registered broker or trading app. Select the desired lot size, enter your bid within the price band, and submit the application before Mon, Jul 29, 2024. The application amount remains blocked until the Clinitech Laboratory IPO allotment is finalized.
What is Clinitech Laboratory IPO Issue Size?
Clinitech Laboratory IPO issue size is ₹5.78 crores.
What is the Clinitech Laboratory IPO Allotment Date?
Clinitech Laboratory IPO allotment date is Tue, Jul 30, 2024.
Who is the Clinitech Laboratory IPO Registrar?
The registrar for Clinitech Laboratory IPO is Bigshare Services Pvt Ltd. Investors can go to Bigshare Services Pvt Ltd website to check Clinitech Laboratory IPO allotment status, refund processing, and other IPO-related information.
What is the Clinitech Laboratory IPO GMP?
The Clinitech Laboratory IPO GMP (Grey Market Premium) is ₹65 as of Thu, Aug 1, 2024. Based on the upper price band of ₹96 per share, the estimated Clinitech Laboratory IPO listing price is ₹161, indicating a potential listing gain of approximately 67.71% over the issue price.
Who is the Clinitech Laboratory IPO Lead Manager?
The book-running lead managers (BRLMs) for the Clinitech Laboratory IPO are . The lead managers are responsible for managing the IPO process, including issue structuring, regulatory compliance, marketing the public issue, coordinating with investors, and ensuring a smooth listing process. For complete details, investors should refer to the Clinitech Laboratory IPO Red Herring Prospectus (RHP).